Tag: Clinical trials
FDA panel rejects MDMA-assisted therapies for PTSD veterans’ hopes dashed.New Title: FDA Panel...
The recent decision by a U.S. Food and Drug Administration (FDA) panel to reject MDMA-based treatments for post-traumatic stress disorder (PTSD) has left many...
More Progress With Less Intensive Treatment, Crucial New Research For People Battling Cancers Like...
New Breakthroughs in Cancer Treatment: Less Intensive Therapy Shows Promise for Ovarian, Esophageal, and Hodgkin Lymphoma PatientsNew research presented at the 2024 American Society...
Is Semaglutide the ‘New Statin’? Not So Fast
Is Semaglutide the Breakthrough Treatment for Obesity and Cardiovascular Disease?
There has been much excitement surrounding the results of the SELECT cardiovascular outcomes trial (CVOT)...
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract CancerThe National Medical Products Administration (NMPA) in China has approved the biologics license application...
Scientists find new method to enhance efficacy of bispecific antibodies for solid tumors
Breakthrough Study Reveals Innovative Approach to Boost Effectiveness of Bispecific Antibodies in Solid Tumor TreatmentA recent study has unveiled a groundbreaking method to enhance...
Ovarian Cancer Drugs Market to Reach USD 9,857 Million by 2032 | Market.us
Ovarian Cancer Drugs Market Projected to Reach USD 9,857 Million by 2032In recent market analysis, the Global Ovarian Cancer Drugs Market is expected to...
Protein Discovery Advances Metabolic Disease Treatment
Protein Discovery Revolutionizes Metabolic Disease Treatment StrategiesA groundbreaking discovery by a University of Saskatchewan (USask) research team has unveiled the remarkable health benefits of...
This New Blood Test Could Help Solve The Mystery of Multiple Sclerosis
New Blood Test Unveiled to Understand Multiple Sclerosis CausesA groundbreaking blood test has been developed to estimate the strength of the immune response in...